Emil T. Kuriakose's Insider Trades & SAST Disclosures

Emil T. Kuriakose's most recent trade in Terns Pharmaceuticals Inc was a trade of 485,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 30, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Terns Pharmaceuticals Inc
Emil T. Kuriakose Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 485,000 485,000 - - Stock Option (Right to Buy)
Terns Pharmaceuticals Inc
Emil T. Kuriakose Chief Medical Officer Sale of securities on an exchange or to another person at price $ 5.71 per share. 02 Jan 2025 4,481 54,269 - 5.7 25,607 Common Stock
Terns Pharmaceuticals Inc
Emil T. Kuriakose Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 120,000 120,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades